Target intelligence / Profile preview

Hepatocyte membrane lipids and proteins

Molecular classification
Other, Transporter, Receptor
01

Overview

The hepatocyte membrane is a complex assembly of phospholipids, cholesterol, and specialized proteins that defines the structural and functional boundary of liver cells (Arias et al., The Liver: Biology and Pathobiology, 2020). It is organized into distinct domains—sinusoidal, canalicular, and lateral—each facilitating specific processes such as nutrient uptake, bile secretion, and cell-cell communication (PubMed, PMID: 31535180). In diseases like viral hepatitis, alcoholic liver disease, and nonalcoholic fatty liver disease (NAFLD), the membrane's lipid composition and protein integrity are often disrupted, leading to cell death or dysfunction. Therapeutic strategies involving this target range from non-specific membrane stabilizers like essential phospholipids and silymarin to highly specific inhibitors of membrane proteins (StatPearls, Silymarin, 2023). For example, bulevirtide targets the NTCP protein to prevent viral entry, while ezetimibe targets NPC1L1 to modulate cholesterol transport (PubMed, PMID: 33035475). Because the term encompasses the entire surface of the hepatocyte, it is considered a broad cellular component rather than a single discrete therapeutic target.

Other names
Hepatocyte plasma membraneLiver cell surface componentsHepatocyte membrane components
02

Mechanism of action

Stabilization of the lipid bilayer, competitive inhibition of membrane-bound transporters (e.g., NTCP, NPC1L1), and modulation of membrane fluidity and permeability to protect against toxic insults.

03

Biological functions

Cellular compartmentalizationTransmembrane transportSignal transductionMetabolic regulationCell-cell communication
04

Disease associations

HepatitisCirrhosisNonalcoholic fatty liver diseaseCholestasisDrug-induced liver injury
05

Safety considerations

Lack of molecular specificityPotential for off-target effects in non-hepatic tissuesVariable bioavailability of lipid-based therapiesPotential for interference with normal physiological transport processes
06

Interacting drugs

Silymarin

4 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)Alkaline phosphatase (ALP)BilirubinGamma-glutamyl transferase (GGT)

Beyond the preview

Go deeper on Hepatocyte membrane lipids and proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte membrane lipids and proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call